We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current BEAM market cap is 1.99B. The company's latest EPS is USD -1.6005 and P/E is -15.03.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 17.19M | 316.19M | 7.41M | 11.77M | 14.27M |
| Operating Income | -108.27M | 132.86M | -104.13M | -104.9M | -106.5M |
| Net Income | -96.09M | 142.8M | -98.67M | -91.05M | -96.67M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 18k | 24k | 51.84M | 60.92M | 377.71M |
| Operating Income | -75.15M | -132.76M | -392.47M | -318.28M | -176.49M |
| Net Income | -91.04M | -194.59M | -370.64M | -289.09M | -132.53M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 1.29B | 1.46B | 1.36B | 1.26B | 1.17B |
| Total Liabilities | 511.59M | 478.39M | 446.31M | 407.17M | 380.05M |
| Total Equity | 778.94M | 981.33M | 913.49M | 854.09M | 791.32M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 156.1M | 451.68M | 1.47B | 1.34B | 1.46B |
| Total Liabilities | 55.15M | 206.12M | 647.72M | 608.24M | 478.39M |
| Total Equity | -201.1M | 245.56M | 826.74M | 733.47M | 981.33M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -284.27M | -149.2M | -99.75M | -182.76M | -270.88M |
| Investing | -26.26M | 71.84M | -53.46M | 34.03M | 58.73M |
| Financing | 242.74M | 276.45M | 2.9M | 3.03M | 4.29M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -72M | -95.74M | -66.27M | 22.53M | -149.2M |
| Investing | -66.66M | -100.12M | -294.14M | -461.34M | 71.84M |
| Financing | 41.28M | 322.32M | 756.14M | 111.59M | 276.45M |
| Market Cap | 1.99B |
| Price to Earnings Ratio | -15.03 |
| Price to Sales Ratio | 5.27 |
| Price to Cash Ratio | 4.57 |
| Price to Book Ratio | 2.03 |
| Dividend Yield | - |
| Shares Outstanding | 82.81M |
| Average Volume (1 week) | 1.49M |
| Average Volume (1 Month) | 1.27M |
| 52 Week Change | -13.58% |
| 52 Week High | 49.50 |
| 52 Week Low | 20.84 |
| Spread (Intraday) | 7.52 (24.64%) |
| Company Name | Beam Therapeutics Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.beamtx.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
